TruBridge Q4 2025 Earnings Call Summary

1Key Financial Results and Metrics

Q4 Revenue: $87.2 million, aligning with revised guidance; a slight decrease of approximately 1% year-over-year.

Full Year Revenue: $346.8 million, a 1.4% increase from 2024.

Adjusted EBITDA: $19.2 million for Q4, representing a margin of 22%, up from 20.4% in Q4 2024; full-year adjusted EBITDA increased 23% to $68.7 million.

Free Cash Flow: $20 million for the year, up $5 million from 2024.

Bookings: Q4 bookings totaled $19.8 million, up from $15.5 million sequentially and $14.3 million year-over-year; total annual bookings were $82.9 million, a 1% increase.

2Strategic Updates and Business Highlights

10-K Filing: The company filed its 10-K with the SEC, noting noncash adjustments related to revenue recognition and costs, emphasizing the commitment to financial reporting standards.

Strategic Review: TruBridge is undergoing a strategic review to maximize shareholder value, with no formal guidance issued for 2026 but expectations for modest revenue growth and 200 basis points of adjusted EBITDA margin improvement.

Pipeline Growth: The sales pipeline is at its highest in nine quarters, with a 53% increase since Q3 2025, and over 70% of the pipeline consists of recurring deals.

AI Strategy: Focus on four pillars—financial health, patient care, customer service, and internal development—with initiatives to improve claims denial predictions and enhance customer service through AI-driven solutions.

3Forward Guidance and Outlook

2026 Expectations: Modest revenue growth anticipated along with approximately 200 basis points of adjusted EBITDA margin improvement. No formal guidance provided due to ongoing strategic review.

4Bad News, Challenges, or Points of Concern

Customer Retention: The company experienced challenges in customer retention, particularly in the CBO segment, with ongoing attrition impacting growth expectations.

Revenue Decline in Patient Care: Patient Care revenue declined by 6.6% year-over-year, primarily due to the sunset of the Centriq product.

Implementation Delays: The conversion of bookings to revenue may be impacted by customer readiness and contract terms, leading to potential delays in revenue recognition.

5Notable Q&A Insights

Bookings and Revenue Conversion: Management discussed the relationship between bookings and revenue, emphasizing the need for effective conversion strategies and the impact of customer transitions.

Strategic Review Timeline: No specific timeline provided for the strategic review process, with a focus on achieving the right outcome for shareholder value rather than adhering to a deadline.

AI Deployment: Management highlighted the cautious approach to AI investments, ensuring that projects deliver tangible ROI without incurring excessive costs.

Partnerships: The partnership with RevSpring is expected to enhance patient collections, although significant impacts are anticipated to materialize in 2026 rather than 2025. This summary encapsulates the key points from the earnings call, providing a balanced view of TruBridge's performance, strategic direction, and challenges ahead.